Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Almirall Hermal GmbH, Scholtzstrasse 3, D-21465, Reinbek, Germany
Curatoderm 4μg/g Ointment.
| Pharmaceutical Form |
|---|
|
Ointment. |
One gram of ointment contains 4μg/g of tacalcitol (4.17μg/g of tacalcitol monohydrate).
Excipients with known effect: Butylhydroxytoluene (E321) contained in the excipient Paraffin, white soft.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Tacalcitol |
Tacalcitol is a vitamin D3 derivative, which inhibits keratinocyte hyper-proliferation and induces differentiation of these cells. The normalisation of these mechanisms is the basis for the efficacy in the treatment of psoriasis. |
| List of Excipients |
|---|
|
Paraffin |
Aluminium tubes with internal lacquer, membrane-sealed opening and plastic screw cap, containing 5g, 20g, 30g or 100g.
Almirall Hermal GmbH, Scholtzstrasse 3, D-21465, Reinbek, Germany
PL 33016/0012
13th July 2006
| Drug | Countries | |
|---|---|---|
| CURATODERM | Austria, Poland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
